Development and Characterization of Pioglitazone Nanoparticles for the Effective Treatment of Diabetes Mellitus
Revathi A. Gupta & P. Odaya Kumar · Journal of Pharmaceutical Research International · 2021
Pioglitazone is designated as a BCS class II medication since it is weakly water soluble.The goal of this study was to create starch nanoparticles for the administration of Pioglitazone in attempt to lessen dose-related side effects and maybe prolong its release in the treatment...
Open access
Research Article
10.9734/jpri/2021/v33i31A31678